A family-based and case-control association study of SOX10 in schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 141, Issue 5, 2006, Pages 477-481

  Iwamoto, Kazuya ^a   Bundo, Miki ^a   Yamada, Kazuo ^a   Takao, Hitomi ^a   Iwayama, Yoshimi ^a   Yoshikawa, Takeo ^a   Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

DNA microarray; Epigenetics; Oligodendrocyte

Indexed keywords

TRANSCRIPTION FACTOR SOX10;

ARTICLE; ASIAN; AUTOPSY; CASE CONTROL STUDY; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; FAMILY STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; OLIGODENDROGLIA; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HIGH MOBILITY GROUP PROTEINS; HUMANS; JAPAN; MALE; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; TRANSCRIPTION FACTORS;

EID: 33745859425     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30304     Document Type: Article

References (33)

1. Aston C, Jiang L, Sokolov BP. 2004. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77(6):858-866.
2. Bunney WE, Bunney BG, Vawter MP, Tomita H, Li J, Evans SJ, Choudary PV, Myers RM, Jones EG, Watson SJ, et al. 2003. Microarray technology: A review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry 160(4):657-666.
3. Chowdari KV, Mimics K, Semwal P, Wood J, Lawrence E, Bhatia T, Deshpande SN, B KT, Ferrell RE, Middleton FA, et al. 2002. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 11(12):1373-1380.
4. Davis KL, Stewart DG, Friedman JI, Buehsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. 2003. White matter changes in schizophrenia: Evidence for myelin-related dysfunction. Arch Gen Psychiatry 60(5):443-456.
5. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2):115-121.
6. Gottesman I. 1991. Schizophrenia genesis: The origins of madness. New York: W.H. Freeman.
7. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98(8):4746-4751.
8. Harrison PJ, Weinberger DR. 2005 Schizophrenia genus, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10(1):40-68.
9. Ide M, Muratake T, Yamada K, Iwayama-Shigeno Y, Iwamoto K, Takao H, Toyota T, Kaneko N, Minabe Y, Nakamura K, et al. 2004. Genetic and expression analyses of FZD3 in schizophrenia. Biol Psychiatry 56(6):462-465.
10. Inoue K, Khajavi M, Ohyama T, Hirabayashi S, Wilson J, Reggin JD, Mancias P, Butler IJ, Wilkinson MF, Wegner M, et al. 2004. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet 36(4):361-369.
11. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. 2004. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 9(4):406-416.
12. Iwamoto K, Bundo M, Kato T. 2005a. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14(2):241-253.
13. Iwamoto K, Bundo M, Yamada K, Takao H, Iwayama-Shigeno Y, Yoshikawa T, Kato T. 2005b. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 25(22):5376-5381.
14. Kato T, Iwayama Y, Kakiuchi C, Iwamoto K, Yamada K, Minabe Y, Nakamura K, Mori N, Fujii K, Nanko S, et al. 2005. Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia. Mol Psychiatry 11:1045-1055.
15. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M. 1998. Sox10, a novel transcriptional modulator in glial cells. J Neurosci 18(1):237-250.
16. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Chondary PV, Lopez JF, Avelar A, Shokoohi V, Chung T, et al. 2004. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13(6):609-616.
17. Lin X, Qin W, He G, Yang Y, Chen Q, Zhou J, Li D, Gu N, Xu Y, Feng G, et al. 2005. A family-based association study of the MOG gene with schizophrenia in the Chinese population. Schizophr Res 73(2-3):275-280.
18. Martin ER, Monks SA, Warren LL, Kaplan NL. 2000. A test for linkage and association in general pedigrees: The pedigree disequilibrium test. Am J Hum Genet 67(1):146-154.
19. Mirnics K, Middleton FA, Lewis DA, Levitt P. 2001a. Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse. Trends Neurosci 24(8):479-486.
20. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. 2001b. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6(3):293-301.
21. Moises HW, Zoega T, Gottesman H. 2002. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2(1):8.
22. Owen MJ, Williams NM, O'Donovan MC. 2004. The molecular genetics of schizophrenia: New findings promise new insights. Mol Psychiatry 9(1):14-27.
23. Qin W, Gao J, Xing Q, Yang J, Qian X, Li X, Guo Z, Chen H, Wang L, Huang X, et al. 2005. A family-based association study of PLP1 and schizophrenia. Neurosci Lett 375(3):207-210.
24. Sham PC, Curtis D. 1995a. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 59(Pt 3):323-336.
25. Sham PC, Curtis D. 1995b. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59(Pt 1):97-105.
26. Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner M, Bartsch U, Wegner M. 2002. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev 16(2):165-170.
27. Sugai T, Kawamura M, Iritani S, Araki K, Makifuchi T, Imai C, Nakamura R, Kakita A, Takahashi H, Nawa H. 2004. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Ann N Y Acad Sci 1025:84-91.
28. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Wehster MJ, Yolken RH, Bahn S. 2003. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362(9386):798-805.
29. Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J, Overman KM, Atz ME, Myers RM, Jones EG, et al. 2004. Effect of agonal and postmortem factors on gene expression profile: Quality control in microarray analyses of postmortem human brain. Biol Psychiatry 55(4):346-352.
30. Wan C, Yang Y, Feng G, Gu N, Liu H, Zhu S, He L, Wang L. 2005. Polymorphisms of myelin-associated glycoprotein gene are associated with schizophrenia in the Chinese Han population. Neurosci Lett 388(31):126-131.
31. Yamada K, Iwayama-Shigeno Y, Yoshida Y, Toyota T, Itokawa M, Hattori E, Shimizu H, Yoshikawa T. 2004. Family-based association study of schizophrenia with 444 markers and analysis of a new susceptibility locus mapped to 11q13.3. Am J Med Genet Part B 127B:11-19.
32. Yang YF, Qin W, Shugart YY, He G, Liu XM, Zhou J, Zhao XZ, Chen Q, La YJ, Xu YF, et al. 2005. Possible association of the MAG locus with schizophrenia in a Chinese Han cohort of family trios. Schizophr Res 75(1):11-19.
33. Zai G, King N, Wigg K, Couto J, Wong GW, Honer WG, Barr CL, Kennedy JL. 2005. Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia. Genes Brain Behav 4(1):2-9.